scholarly article | Q13442814 |
P356 | DOI | 10.1016/0264-410X(90)90051-M |
P698 | PubMed publication ID | 2363300 |
P50 | author | David Tyrrell | Q3018902 |
P2093 | author name string | Robinson BS | |
Watt PJ | |||
Pringle CR | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
P304 | page(s) | 231-236 | |
P577 | publication date | 1990-06-01 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines | |
P478 | volume | 8 |
Q39398631 | Analysis of respiratory syncytial virus strain variation in successive epidemics in one city |
Q45460509 | Antigen-dependent proliferation and cytokine induction in respiratory syncytial virus-infected cotton rats reflect the presence of effector-memory T cells |
Q33801890 | CD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment |
Q45480836 | Comparison of affinity chromatography and adsorption to vaccinia virus recombinant infected cells for depletion of antibodies directed against respiratory syncytial virus glycoproteins present in a human immunoglobulin preparation. |
Q38790481 | Controlled human infection with RSV: The opportunities of experimental challenge |
Q45742833 | Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H. |
Q45872879 | Epitope specificities of human serum antibodies reactive with respiratory syncytial virus fusion protein |
Q35091812 | Feasibility of aerosol vaccination in humans |
Q35618515 | Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus |
Q36539394 | Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses |
Q33683058 | Intranasal antibody prophylaxis for protection against viral disease. |
Q40076730 | Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus |
Q35823116 | Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice |
Q36689031 | Live vaccines for human metapneumovirus designed by reverse genetics |
Q36692801 | Live-attenuated respiratory syncytial virus vaccines |
Q34191801 | Molecular epidemiology of respiratory syncytial virus |
Q47340692 | Mothers may transmit RSV infection more easily or severely to sons than daughters: community study from Guinea-Bissau |
Q39695161 | Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein. |
Q42207071 | Polyclonal and monoclonal antibodies specific for the six-helix bundle of the human respiratory syncytial virus fusion glycoprotein as probes of the protein post-fusion conformation. |
Q45722102 | Prevalence of anti-human respiratory syncytial virus antibodies over three consecutive years in a healthy adult population. |
Q56894869 | Progress in respiratory virus vaccine development |
Q40836386 | Respiratory syncytial virus (RSV) disease and prospects for its control |
Q33961877 | Respiratory syncytial virus infection in adults |
Q43617842 | Respiratory syncytial virus vaccine: a systematic overview with emphasis on respiratory syncytial virus subunit vaccines |
Q45377065 | Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection. |
Q64117055 | Systematic comparison of respiratory syncytial virus-induced memory B cell responses in two anatomical compartments |
Q35108669 | Using mathematical transmission modelling to investigate drivers of respiratory syncytial virus seasonality in children in the Philippines |
Q35843602 | Vaccines for neonatal viral infections: towards a live respiratory syncytial virus vaccine:a study in risk |
Q24201977 | Vaccines for the common cold |
Q38682527 | Vaccines for the common cold |
Search more.